foxconn shut protection for the apple iphone 13 for six days. as you have said, shut production. some car manufacturers have had to. the component makers in taiwan are now having to stop making things like circuit boards and touch screen modules which go into those iphones and those cars. and there is a bit of an unknown factor here in the rise in the number of cases, the mix of delta and 0micron, we don t know how people will be impacted health wise. know how people will be impacted health-wise. yes, there were impacted health-wise. yes, there were some impacted health-wise. yes, there were some stories - impacted health-wise. yes, - there were some stories before that that vaccine wasn t as effective against 0micron, so there could be one of the issues. we don t know how delta and 0micron will play out against that. one of the things that the tech names are being so hit, it is notjust the supply chains, there are some moves to delist some chinese based tech stocks in the us,
vaccine wasn t sold you wouldn t get infected what it said was nearly impossible for you to have to be hospitalized or die from covid-19. those are the things that we should be fearful of. excess of hospitalizations or death, obviously. so, what the president s message tomorrow should be is be very clear. we need to move on with our lives. i urge every american to get vaccinated. and make sure that if you get that vaccination, and you are eligible you get a booster shot. because, what the statistics show is that if that happens your likelihood of getting sick from any of these variants is almost zero. brian: 98, sometimes 95% effective and we both know so many people with break through cases not ending up in the hospital but a lot of break through cases and there seems to be a lack of acknowledgment of the number of break through cases and i m really concerned about the data we are given is
up. it s best to leave the skigss to the local areas since there s so much variation in covid around the country and probably will be during the course of the career. let s talk boosters. as we mentioned you serve as an independent director on johnson & johnson s board. where s the data for j&j s vaccine? why are people who got that vaccine still in the dark when it comes to whether they need a booster? it s a great question. that data is coming. as you remember, the pfizer and moderna vaccines were approved first. they were administered in december. the j&j vaccine wasn t approved until a couple months later. the studies are in process. there s every expectation they re going to be done soon in time to make sure that everybody who had any of these three vaccines gets some clear guidance about the best next steps for them by that september 20th or there abouts, date that the federal governments announce when they want to start doing the booster shots. but remember, ana, the first
intensive care units, they ve decided they should go for one dose initially. and if you do that, if you made the gap to four weeks apart, which is what they have been doing with the pfizer biontech, you can now do three times as many people with an initial dose. now although the astrazeneca oxford vaccine wasn t quite as effective as the pfizer jab or vaccine wasn t quite as effective as the pfizerjab or in its trials, percentages can vary when you get into a real world situation, nobody who got at least one dose of the oxford vaccine was hospitalised with covid. so it should prevent severe illness. that really is the most important thing at the moment. other questions as well. we know from what they are saying that those of the most high risk groups will be prioritised. then we had a list previously. do we know about what order people would be vaccinated in